Evidence map›Paper›PMID 33995474›Full record

ArticleFrontiers in genetics2021

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome.

Jie Huang, Xiang Wang, Xue Zhang, Weijie Chen, Lijuan Luan, Qi Song, Hao Wang, Jia Liu, Lei Xu, Yifan Xu and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jie HuangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiang WangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xue ZhangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Weijie ChenDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lijuan LuanDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Qi SongDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Hao WangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Jia LiuDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lei XuDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yifan XuDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Licheng ShenDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lijie TanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Dongxian JiangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jieakesu SuDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yingyong HouDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Fudan University · CNZhongshan Hospital · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we aimed to investigate the clinical and prognostic values of

Indexed as

CDK4 amplificationclinical stageesophageal squamous cell carcinomafluorescence in situ hybridizationprognostic value

Identifiers

PMID33995474
PMCPMC8116700
OpenAlexW3158601495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.